Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.3.0.814
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Cash flows from operating activities:    
Net loss $ (1,635) $ (2,087)
Less: (loss) income on discontinued operations (1,313) 1,633
Loss from continuing operations (322) (3,720)
Adjustments to reconcile net loss from continuing operations to cash provided by (used in) operations:    
Depreciation and amortization 2,821 3,282
Amortization of debt discount 65 65
Deferred tax expense 107 90
(Recovery of) provision for bad debt reserves $ (27) 11
Impairment loss on goodwill (380)
Gain on disposal of plant, property and equipment $ (23) (41)
Loss on sale of SYA subsidiary 48
Issuance of common stock for services $ 220 198
Stock-based compensation 62 (2)
Changes in operating assets and liabilities of continuing operations:    
Accounts receivable (164) (1,960)
Unbilled receivables 1,354 (1,246)
Prepaid expenses, inventories and other assets 795 709
Accounts payable, accrued expenses and unearned revenue (3,404) 801
Cash provided by (used in) continuing operations 1,484 (1,385)
Cash used in discontinued operations (1,233) (1,959)
Cash provided by (used in) operating activities 251 (3,344)
Cash flows from investing activities:    
Purchases of property and equipment (338) (375)
Proceeds from sale of property and equipment 27 133
Proceeds from sale of SYA subsidiary (Note 11) 50 1,218
Payment to finite risk sinking fund (30) (19)
Cash (used in) provided by investing activities of continuing operations $ (291) 957
Proceeds from property insurance claims of discontinued operations 5,727
Cash (used in) provided by investing activities $ (291) 6,684
Cash flows from financing activities:    
Borrowing of revolving credit 49,783 60,899
Repayments of revolving credit borrowings (49,476) (60,899)
Principal repayments of long term debt (1,742) (1,852)
Principal repayments of long term debt - related party (1,125) $ (125)
Proceeds from stock subscription - Perma-Fix Medical S.A., net of expenses of $29 971
Proceeds from issuance of common stock 10 $ 4
Cash used in financing activities of continuing operations $ (1,579) (1,973)
Principal repayments of long term debt for discontinued operations (27)
Cash used in financing activities $ (1,579) $ (2,000)
Effect of exchange rate changes on cash (63)
(Decrease) increase in cash (1,682) $ 1,340
Cash at beginning of period 3,680 333
Cash at end of period 1,998 1,673
Supplemental disclosure:    
Interest paid 404 498
Income taxes paid 116 $ 30
Proceeds from stock subscription for Perm-Fix Medical S.A. held in escrow $ 67